FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23903111000001109: Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Feb 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77443801000001111 Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78324301000001117 Erythromycin ethyl succinate 500mg/5ml oral suspension (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Is a Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) 100 ml Has AMP True Erythromycin ethyl succinate 500mg/5ml oral suspension (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start